InfinixBio Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • InfinixBio's estimated annual revenue is currently $3.3M per year.(i)
  • InfinixBio's estimated revenue per employee is $155,000

Employee Data

  • InfinixBio has 21 Employees.(i)
  • InfinixBio grew their employee count by 75% last year.

InfinixBio's People

NameTitleEmail/Phone
1
VP PharmacokineticsReveal Email/Phone
2
Project MangerReveal Email/Phone
3
Project MangerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.8M50%N/AN/A
#2
$1.7M110%N/AN/A
#3
$0.8M50%N/AN/A
#4
$5.1M3314%N/AN/A
#5
$64.6M4172%N/AN/A
#6
$1.7M11-8%N/AN/A
#7
$0.8M50%N/AN/A
#8
$7.4M48-41%N/AN/A
#9
$0.6M40%N/AN/A
#10
$0.9M1220%N/AN/A
Add Company

What Is InfinixBio?

InfinixBio operates as a Contract Research Organization working with Entrepreneurs, Biotech Incubators, Biotech Companies, and Investors. Our goals are to advance our clients’ technology from concept to reality, to improve how their product works, and/or adapt their product to meet unmet or unarticulated market needs. The team consists of 30+ experienced scientists - 16 Ph.D.’s - from across the globe with deep domain expertise in genes, proteins, and cells, and has delivered creative solutions to many difficult problems in Biotechnology product development. Our locations are in Athens and Columbus, Ohio near universities allowing us to have unique access to resources. We are also able to facilitate a diversity of expertise in problem resolution. “We’ve found that to deliver the best solutions to our clients, we rely on the great diversity of our people. People from different backgrounds and walks of life bring different perspectives enabling creative solutions to challenging problems.” -Nick Henderson, CEO

keywords:N/A

N/A

Total Funding

21

Number of Employees

$3.3M

Revenue (est)

75%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4M21-12%N/A
#2
$2.1M21N/AN/A
#3
$4.7M2124%N/A
#4
$4M2131%N/A
#5
N/A2117%N/A